Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1

Por Wheeler, T.M., Krym, M.C., Thornton, C.A.
Publicado em 2007

Signal transducer and activator of transcription-3 licenses Toll-like receptor 4-dependent interleukin (IL)-6 and IL-8 production via IL-6 receptor-positive feedback in endometrial...

Por Cronin, J G, Kanamarlapudi, V, Thornton, C A, Sheldon, I M
Publicado no Mucosal Immunol (2016)

Health education in schools.

Por Thornton, C A, Brennan, R K, Browne, A D, Denham, P C
Publicado em 1978

Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR.

Por Tian, B, White, R J, Xia, T, Welle, S, Turner, D H, Mathews, M B, Thornton, C A
Publicado em 2000

Bioenergetic analysis of human peripheral blood mononuclear cells

Por Jones, N, Piasecka, J, Bryant, A H, Jones, R H, Skibinski, D O F, Francis, Nigel J, Thornton, C A
Publicado no Clin Exp Immunol (2015)

Human gestation‐associated tissues express functional cytosolic nucleic acid sensing pattern recognition receptors

Por Bryant, A. H., Menzies, G. E., Scott, L. M., Spencer‐Harty, S., Davies, L. B., Smith, R. A., Jones, R. H., Thornton, C. A.
Publicado no Clin Exp Immunol (2017)

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 [Image: see text]

Por Logigian, E.L., Martens, W.B., Moxley, R.T., McDermott, M.P., Dilek, N., Wiegner, A.W., Pearson, A.T., Barbieri, C.A., Annis, C.L., Thornton, C.A., Moxley, R.T.
Publicado em 2010

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

Por Sorenson, E J., Windbank, A J., Mandrekar, J N., Bamlet, W R., Appel, S H., Armon, C, Barkhaus, P E., Bosch, P, Boylan, K, David, W S., Feldman, E, Glass, J, Gutmann, L, Katz, J, King, W, Luciano, C A., McCluskey, L F., Nash, S, Newman, D S., Pascuzzi, R M., Pioro, E, Sams, L J., Scelsa, S, Simpson, E P., Subramony, S H., Tiryaki, E, Thornton, C A.
Publicado em 2008